瑞港集團(00357.HK)擬延長母公司認購事項新H股發行議案有效期
格隆匯9月24日丨瑞港集團(00357.HK)公佈,考慮到有關母公司認購事項及新H股發行各項的有關決議案的有效期將於2019年9月25日屆滿,為確保董事會完成該等母公司認購事項及新H股發行,董事會擬召開股東特別大會及類別股東大會讓股東考慮(其中包括)延長決議案(包括母公司認購事項延長決議案及新H股發行延長決議案),以通過特別決議案方式,將股東決議案以及授予董事會處理及完成母公司認購事項及新H股發行的權限的有效期進一步延長9月。母公司及其聯繫人將放棄就母公司認購事項延長決議案進行表決。新H股發行須待中國證監會批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.